Deals & Cases
MLL Legal advised Earlybird in its Series A investment in Rivia AG
MLL Legal advised lead investor Earlybird on all legal aspects of its investment in Rivia AG’s $15 million Series A financing round
Rivia AG, a Zurich-based start-up, has developed an AI platform that streamlines the entire data operations layer of clinical trials. The platform integrates diverse data sources in real time, automates quality control and monitoring, and provides clinical teams with instant, queryable access to trial data. The new funding will allow Rivia to enhance its platform, accelerate international expansion, and strengthen its position as a leader in agentic AI-driven clinical trial solutions
MLL Legal advised lead investor Earlybird on all legal aspects of the transaction.
The MLL Legal team was led by partner Daniel Schoch (Corporate and M&A) and included partner Michael Reinle (ICT), as well as Andreas Bossard (Corporate & M&A)
